Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.8B | 14.6B | 11.1B | 12.4B |
Cost of revenue | 8.9B | 12.9B | 9.1B | 10.3B |
Gross profit | 1.9B | 1.8B | 2.0B | 2.1B |
Operating expense | ||||
Research & development | 264.4M | 471.0M | 213.2M | 366.4M |
Selling general and admin | 280.6M | -493.4M | 647.0M | -150.0M |
Other operating expenses | 8.0M | 32.1M | 19.5M | 22.9M |
Operating income | 1.4B | 866.2M | 1.5B | 1.6B |
Non operating interest income | ||||
Income | 19.3M | 27.1M | 31.8M | 24.9M |
Expense | 161.7M | 121.6M | 200.8M | 210.8M |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 1.0B | 1.2B | 1.5B |
Tax provision | 192.5M | 258.0M | 310.8M | 449.9M |
Net income | 936.7M | 762.6M | 926.9M | 1.0B |
Basic EPS | 0.2 | — | — | — |
Diluted EPS | 0.2 | — | — | — |
Basic average shares | 38.5B | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 1.3B | 1.1B | 1.4B | 1.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | -49.5M | -70.3M | -74.5M | -62.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |